Financials
Financial year 2025
PHARMA SWITCH from Merchtem, company number BE0705903444, closed financial year 2025 with a result of € 1,356 after tax. For that financial year PHARMA SWITCH recorded a gross margin of € 4,402 and equity of € 1,644. Compared with financial year 2024, the result moved from € -1,703 to € 1,356. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2026.
€ 1,644
▲ € 1,356 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1,356
▲ still € 1,703 loss in 2024
Profit after tax over the fiscal year.
€ 6,953
▲ € 6,777 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -4,556.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,114
▲ 26% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,170
▼ 23% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 9,096 | € 5,660 | € 5,371 | € 4,402 | ▼ 18% |
| Profit after taxes | € 1,015 | € -1,498 | € -1,703 | € 1,356 | ▲ € 3,059 |
| Equity | € 3,489 | € 1,991 | € 288 | € 1,644 | ▲ € 1,356 |
| Total debts | € 16,197 | € 9,641 | € 7,075 | € 7,801 | ▲ 10% |
| Cash | € 4,936 | € 3,280 | € 176 | € 6,953 | ▲ € 6,777 |
| Retained profit | € -2,711 | € -4,209 | € -5,912 | € -4,556 | ▲ € 1,356 |
| Bank debt | € 7,982 | € 618 | € 0 | € 0 | |
| Balance sheet total | € 19,686 | € 11,632 | € 7,363 | € 9,444 | ▲ 28% |
By gross margin, PHARMA SWITCH ranks 10th of 11 companies with main activity “Detailhandel in farmaceutische producten” in Merchtem that publish figures (fiscal year 2025).
Key figures of PHARMA SWITCH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMA SWITCH the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMA SWITCH?
What happened at PHARMA SWITCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1,356. Source: NBB ↗
- New establishment in Merchtem. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,015 profit in 2022 to € 1,356 profit in 2025.
Paid € 5,068 in corporate taxes since 2022.
Best year ever: 2025, with € 1,356 profit.
Management
Behind PHARMA SWITCH is GUY BOULANGER.
Directors
According to the 2025 annual accounts
GUY BOULANGER
Director
Establishments
Establishment units
Physical locations of this company
Wolvertemsesteenweg 35
1785 Merchtem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Merchtem
Same main activity (Detailhandel in farmaceutische producten), 11 active companies in Merchtem, largest first.
€ 421,539 gross margin · 2025
€ 332,485 gross margin · 2025
€ 204,749 gross margin · 2025
€ 192,684 gross margin · 2025
€ 181,427 gross margin · 2025
€ 175,020 gross margin · 2025
Details
- Company number
- 0705.903.444
- VAT number
- BE 0705.903.444
- Registered office
- Wolvertemsesteenweg 35, 1785 Merchtem
- Names & denominations
- PHARMA SWITCH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 September 2018
- Peppol
- Active · Active since 31 Mar 2026
- Activities · NACE
Detailhandel in farmaceutische producten